12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

d-Amphetamine Transdermal System: Phase II started

Hisamitsu's Noven Pharmaceuticals Inc. subsidiary began a double-blind, placebo-controlled, crossover Phase II trial to evaluate d-ATS...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >